Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study | ||
| dc.conicet.organizacion | Clínica de Especialidades Altamira | |
| dc.conicet.organizacion | Universidad San Carlos de Guatemala | |
| dc.conicet.organizacion | Hospital Juan de Dios de San Pedro | |
| dc.conicet.organizacion | Instituto de Salud Mental | |
| dc.conicet.organizacion | Colonia Médica | |
| dc.conicet.organizacion | Clínica de la Conducta | |
| dc.conicet.organizacion | Corporación Farmacéutica Recalcine | |
| dc.conicet.organizacion | Corporación Farmacéutica Recalcine | |
| dc.conicet.organizacion | Etymos Consulting Group | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas | |
| dc.contributor.author | Molina, Luis | |
| dc.contributor.author | Recinos, Byron | |
| dc.contributor.author | Paz, Bezner | |
| dc.contributor.author | Rovelo, Mauricio | |
| dc.contributor.author | Elias Rodriguez, Fanny Elizabeth | |
| dc.contributor.author | Calderón, José | |
| dc.contributor.author | Arellano, Arturo | |
| dc.contributor.author | Pomata, Santiago | |
| dc.contributor.author | Rey, María Verónica | |
| dc.contributor.author | Pérez Lloret, Santiago | |
| dc.date.issued | 2016-03 | |
| dc.description.abstract | Background and Objectives The first weeks of treatment with antipsychotics are important for the development of their long-term efficacy. The objective of this study was to identify factors related to early clinical effects and quality of life (QoL) improvements with quetiapine extended-release (XR). Methods Six hundred and sixty-five patients starting with quetiapine XR were followed up for 8 weeks (schizophrenia = 153, major depression = 200, bipolar depression = 252, other psychiatric conditions = 60). Clinical effects were assessed by the Clinical Global Impression of Change scale (CGI-C), QoL by the visual analog scale (VAS) of the EQ-5D (QoL-VAS), and adherence by the Moriksy scale. Adverse events were explored: movement disorders by the UKU and Simpson-Angus scales, weight gain by calibrated balances, and diurnal somnolence by the Epworth Somnolence Scale (ESS). Results The mean dose of quetiapine XR during follow-up was 195.6 ± 154.8 mg/day. CGI and QoL-VAS scores improved significantly at week 8 by 2.7 ± 0.1 points and 25.1 ± 0.9 points. Adverse events were observed in 34 and 26 % of patients at weeks 4 and 8, respectively. A significant reduction in ESS score was also observed at week 8. Factors independently associated with change in QoL-VAS ≥20 points (n = 292, 43 %) were female gender, more severe disease at baseline, higher antipsychotic dose during follow-up, and improvements in somnolence. Factors independently associated with clinically significant improvement (CGI-C ≥5, n = 610, 93 %) were greater change in QoL-VAS, less frequent movement disorders at baseline, and lack of adverse events during follow-up, especially somnolence. Conclusions Results from this real-setting, large observational study in Central America suggest that disease severity at baseline, gender, antipsychotic dose, and occurrence of adverse reactions has a significant impact on the early clinical effects of quetiapine XR. | es |
| dc.description.fil | Fil: Molina, Luis. Clínica de Especialidades Altamira; Nicaragua | |
| dc.description.fil | Fil: Recinos, Byron. Universidad San Carlos de Guatemala; Guatemala | |
| dc.description.fil | Fil: Paz, Bezner. Hospital Juan de Dios de San Pedro; Honduras | |
| dc.description.fil | Fil: Rovelo, Mauricio. Instituto de Salud Mental; Honduras | |
| dc.description.fil | Fil: Elias Rodriguez, Fanny Elizabeth. Colonia Médica; El Salvador | |
| dc.description.fil | Fil: Calderón, José. Clínica de la Conducta; Panamá | |
| dc.description.fil | Fil: Arellano, Arturo. Corporación Farmacéutica Recalcine; Costa Rica | |
| dc.description.fil | Fil: Pomata, Santiago. Corporación Farmacéutica Recalcine; Costa Rica | |
| dc.description.fil | Fil: Rey, María Verónica. Etymos Consulting Group; Argentina | |
| dc.description.fil | Fil: Pérez Lloret, Santiago. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Molina, Luis; Recinos, Byron; Paz, Bezner; Rovelo, Mauricio; Elias Rodriguez, Fanny Elizabeth; et al.; Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study; Springer; Clinical Drug Investigation; 36; 6; 3-2016; 491-497 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1173-2563 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/41808 | |
| dc.journal.ciudad | Berlín | es |
| dc.journal.number | 6 | es |
| dc.journal.pagination | 491-497 | es |
| dc.journal.pais | Alemania | es |
| dc.journal.title | Clinical Drug Investigation | es |
| dc.journal.volume | 36 | es |
| dc.language.iso | eng | es |
| dc.publisher | Springer | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007%2Fs40261-016-0395-x | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1007/s40261-016-0395-x | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Ezquisofrenia | es |
| dc.subject | Depresion | es |
| dc.subject | Quetipina | es |
| dc.subject | Efectos Tempranos | es |
| dc.subject.classification | Medicina Critica y de Emergencia | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.32f476de-d751-4963-b621-6a17c27125cd_A.pdf
- Tamaño:
- 1.05 MB
- Formato:
- Adobe Portable Document Format